Skip to content

TAP Block Versus Local Anesthesia Wound Infiltration for Postoperative Pain Relief After Appendicectomy in Children

TAP Block Versus Local Anesthesia Infiltration at Wound Site for Postoperative Pain Relief After Laparoscopic Appendicectomy in Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04969133
Acronym
PABLO
Enrollment
110
Registered
2021-07-20
Start date
2021-07-30
Completion date
2024-01-31
Last updated
2025-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Appendicitis Acute, Pediatrics

Keywords

Appendicectomy, Laparoscopy, infiltration, TAP block

Brief summary

When performing laparoscopic appendectomy in children, regional anesthetic techniques are rou-tinely used concomitantly with general anesthesia. These techniques include local infiltration of the trocar wounds or transverse abdominal plane block (TAP block). In 2018, a position paper of the European Society of Pediatric Anaesthesiology advised for TAP block over local infiltration of the trocar wounds. However, there is no randomized study comparing both techniques in children. The aim of this study is to compare morphine consumption during the first 24 postoperative hours in children undergoing laparoscopic appendectomy and randomly allocated to either local infiltration of the trocar wounds or TAP block.

Detailed description

This is a double blind randomized study with two parallel groups. Children between 3 and 15 years of age with indication of laparoscopic appendectomy will be approached for inclusion in this trial. Informed consent will be asked for from the parents and the child. Before surgery, patients will be randomized to either local infiltration of the trocar wounds or TAP block using sequentially numbered sealed envelope each with a random number inside. Patients with peritonitis will be excluded. A standardized analgesia protocol within the first 24 post-operative hours will be applied and the primary outcome is nalbuphine consumption during this time frame. Secondary outcomes include postoperative pain (FLACC assessment tool) and postoperative nausea and vomiting.

Interventions

To compare TAP block versus local infiltration of the trocar wounds with levobupivacaine 2.5 mg/ml for post operative pain relief after laparoscopic appendicectomy in children

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* Age betwween 3 and 15 years * Weight \< or = 50 kg * indicaction of coelioscopic appendicectomy * ASA 1,2 or 3 * consent of the children and the holder of parental autority

Exclusion criteria

* Age\<3 years or \> 15years or weight \> 50kg * refusal of the children and the holder of parental autority * ASA 4 * Peritonitis * Patients with long term morphinic traitment * Epilepsy * Hepato-cellular insuffisiancy * local anesthesia allergy or nalbuphine allergy * coagulation abnomrmality * exclusion of health insurance

Design outcomes

Primary

MeasureTime frameDescription
cumulative dose of nalbuphine in the 24 first hours post surgery24 hoursrecording in mg/kg

Secondary

MeasureTime frameDescription
cumulative dose of nalbuphine H13-H24 post surgeryFrom 13th hour to 24th hourrecording in mg/kg
FLACC analgesia score at H1 H2 H6 H12 H24FLACC score will be performed from awakenig to 24 hours post surgeryFace Leg Activity Cry Consolability heteroevaluation scale from 0 to 10
FLACC score meanFLACC score will be performed from awakenig to 24 hours surgeryFace Leg Activity Cry Consolability heteroevaluation scale from 0 to 10
individual variations of FLACC scoreFLACC score will be performed from awakenig to 24 hours surgeryFace Leg Activity Cry Consolability heteroevaluation scale from 0 to 10
cumulative dose of nalbuphine H0-H12 post surgeryfrom beginning to 12th hourrecording in mg/kg
incidence of post operative nausea and vomitingin the first 24 post operative hoursrecording the incidence post operative nausea and vomiting
timing of first standing upin the first 24 post operative hoursrecording date and time of first standing up
adverse eventsin the first 24 post operative hoursadverse event monitoring
timing of first injection of nalbuphinein the first 24 post operative hoursrecording date and time of first injection

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026